TNFRSF1B and plasma cell myeloma: TNFR2 expression has been identified in at least 25 different tumor types, including human renal cell carcinoma, multiple myeloma, colorectal cancer, ovarian cancer, and CTCL (cutaneous T-cell lymphoma) [40].